Earlier detection, enhanced workflow
ScreenPoint Medical (screenpoint-medical.com) scores 66 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Technology brands, in the 13th percentile of 16754 Healthcare brands.
ScreenPoint Medical is a healthcare technology company that develops Transpara Breast AI, an artificial intelligence tool designed to assist radiologists in reading 2D and 3D mammograms. The company's mission is to build AI-powered technology across the breast imaging continuum, aiming to improve consistency, reduce diagnostic uncertainty, and support earlier breast cancer detection. It targets breast imaging providers, radiologists, and healthcare systems facing radiologist shortages and increasing patient volumes.
| Brand Name | ScreenPoint Medical |
|---|---|
| Domain | screenpoint-medical.com |
| Industry | Healthcare, Technology |
| Main Competitors | iCAD (78/100), Lunit (84/100), Volpara Health (75/100), Therapixel (78/100), Densitas (54/100) |
Moz Domain Authority 37/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Transpara Breast AI by ScreenPoint Medical offers earlier detection and enhanced workflow when reading 3D and 2D mammograms. Explore our AI solutions." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, HubSpot.
Social footprint: verified profiles on Facebook, Instagram; no detected presence on LinkedIn, X (Twitter), YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is ScreenPoint Medical?", Claude could identify the brand as of October 2026. ScreenPoint Medical is a Dutch health-tech company that develops Transpara, an AI-based software platform for breast cancer detection in mammography and tomosynthesis imaging, used to assist radiologists in screening programs. Best known for Transpara, its AI software for breast cancer detection in mammography screening.
When asked "Best brands similar to ScreenPoint Medical?", Claude would recommend ScreenPoint Medical as of October 2026. It's one of the more established and clinically validated AI mammography detection companies, so it would be a natural mention alongside names like Volpara or iCAD when discussing breast cancer screening AI.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ScreenPoint Medical's main competitors in Healthcare: iCAD (78/100), Lunit (84/100), Volpara Health (75/100), Therapixel (78/100), Densitas (54/100).
Sources: Brand Analyzer scan
ScreenPoint Medical offers Transpara Breast AI, an artificial intelligence solution for reading 2D and 3D mammograms. It is designed to support radiologists by acting as a 'second pair of eyes,' aiding earlier breast cancer detection and enhancing clinical workflow in breast imaging programs.
Sources: ScreenPoint Medical official site
ScreenPoint Medical has low AI-search visibility, scoring 18/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 22, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: ScreenPoint Medical official site
ScreenPoint Medical builds AI-powered software for breast imaging. Its product, Transpara Breast AI, analyzes 2D and 3D mammograms to act as a 'second pair of eyes' for radiologists, helping detect breast cancer earlier and improving workflow efficiency in screening programs.
Sources: ScreenPoint Medical official site
ScreenPoint Medical scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: ScreenPoint Medical official site
ScreenPoint Medical is a healthcare technology company that develops artificial intelligence software for breast imaging, specifically its flagship product Transpara Breast AI, used to assist radiologists in interpreting mammograms.
Sources: ScreenPoint Medical official site
ScreenPoint Medical can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: ScreenPoint Medical official site
ScreenPoint Medical is known for developing Transpara Breast AI, an AI tool that supports radiologists in reading 2D and 3D mammograms to aid earlier breast cancer detection and improve clinical workflow.
Sources: ScreenPoint Medical official site
Transpara Breast AI is used by breast imaging providers, radiologists, and healthcare systems involved in breast cancer screening programs, particularly those seeking AI-driven support for mammogram interpretation amid radiologist shortages and increasing patient volumes.
Sources: ScreenPoint Medical official site
ScreenPoint Medical scores 18/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ScreenPoint Medical has a weak AI-visibility profile at 18/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 37/100. In a live check, Claude could already identify ScreenPoint Medical from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to ScreenPoint Medical: Sciences Po Strasbourg (66/100), Science.bio (66/100), rScriptor (66/100), Seismic Therapeutic (66/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.